Cetuximab is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body's immune system.
Nausea, Headache, Vomiting, Conjunctivitis, Skin rash, Diarrhoea, Infusion reaction, Decreased magnesium level in blood, Increased liver enzymes
Cetuximab is used in the treatment of head and neck cancer and cancer of colon and rectum.
Cetuximab is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers
Q. Is Cetuximab cytotoxic agent or vesicant or radiosensitizer?It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant)
Q. Is Cetuximab US FDA approved?Yes, Cetuximab is approved by US FDA in 2009 to treat certain type of cancer of colon, rectum and head-neck cancer
Q. How is Cetuximab administered?Cetuximab is generally administered by intravenous (IV infusion) route, with or without radiotherapy
Q. How is Cetuximab administered?Cetuximab is generally administered by intravenous (IV infusion) route, with or without radiotherapy
Q. Does Cetuximab cause hair loss?Yes. Cetuximab is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect
Q. Why does Cetuximab cause a rash?Cetuximab may cause rashes
Q. How long does the rash last?The duration of skin rash depends upon its type and severity. Please consult your doctor for advice.